Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

Initial Therapy for mRCC: Pro: Immune Checkpoint Inhibitors

Editor By No Comments1 Min Read

Hans Hammers MD, PhD of Johns Hopkins presents “Initial Therapy for mRCC: Pro: Immune Checkpoint Inhibitors” at the 14th International Kidney Cancer Symposium.

Share.

Related Posts